5-Bromo-2-chloro-4-methylpyridine

We are 5-Bromo-2-chloro-4-methylpyridine CAS:778611-64-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 778611-64-6
Product Name: 5-Bromo-2-chloro-4-methylpyridine
Other Name:
5-Bromo-2-chloro-4-methylpyridine
2-Chloro-4-methyl-5-bromo pyridine
 
Density: 1.6±0.1 g/cm3
Boiling Point: 239.4±35.0 °C at 760 mmHg
Melting Point: 25-30ºC
Molecular Formula: C6H5BrClN
Molecular Weight: 206.468
Flash Point: 98.6±25.9 °C
Exact Mass: 204.929382
PSA: 12.89000
LogP: 2.82
Vapour Pressure: 0.1±0.5 mmHg at 25°C
Index of Refraction: 1.571
 
Specification
Appearance: Light yellow transparent liquid or solid
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate, organic synthesis intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated 
 
place.

5-Bromo-2-chloro-4-methylpyridine


Related News: With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.N-[3-[5-bromo-1-(2,6-dichlorobenzoyl)pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]propane-1-sulfonamide CAS:1262985-24-9 “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.ácido glutárico CAS:110-94-1 “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.2 ', 2'-difluoro-2'-desoxicitidina-3', 5'-dibenzoato CAS:134790-39-9 Human iPSCs possess the unique dual properties of unlimited self-renewal and differentiation potential into all cell types of the body.These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders — in addition to Ed Damiano — include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible.

Related Products
Product Name
4-Ethylcyclohexanone Cas:5441-51-0 View Details
2-chloro-4-(piperidin-1-ylmethyl)pyridine,oxalic acid View Details
Tetrahydropyran-4-methanol Cas:14774-37-9 View Details
Sarcosine Cas:107-97-1 manufacturer Tetrabutylammonium iodide Cas:311-28-4 manufacturer Bis(ethylcyclopentadienyl)ruthenium Cas:32992-96-4 manufacturer 2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole Cas:152628-02-9 manufacturer 2-(4-chlorophenyl)-3-methylbutanenitrile manufacturer